Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NASH - Nonalcoholic Steatohepatitis; NAFLD - Nonalcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04369521
What this trial is testing

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
National Nutrition and Food Technology Institute 50
Post-approval studies (Phase 4)Study completedNCT07363707
What this trial is testing

A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.

Who this might be right for
NAFLD (Nonalcoholic Fatty Liver Disease)
Beni-Suef University 108
Not applicableStudy completedNCT02860884
What this trial is testing

Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverNon-alcoholic Fatty Liver Disease
Rennes University Hospital 136
Testing effectiveness (Phase 2)Study completedNCT05232071
What this trial is testing

Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus

Who this might be right for
NASH - Nonalcoholic SteatohepatitisDiabetes Mellitus, Type 2
Inventiva Pharma 39
Testing effectiveness (Phase 2)Study completedNCT04880031
What this trial is testing

BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)
GlaxoSmithKline 231
Testing effectiveness (Phase 2)Ended earlyNCT03953456
What this trial is testing

Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)

Who this might be right for
Non-Alcoholic Fatty Liver
Genfit 17
Not applicableUnknownNCT03968354
What this trial is testing

NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)

Who this might be right for
Diabetes type2NASH - Nonalcoholic SteatohepatitisNAFLD
Assistance Publique - Hôpitaux de Paris 50
Not applicableActive Not RecruitingNCT04595474
What this trial is testing

Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic SteatohepatitisFibrosis, Liver+2 more
Joslin Diabetes Center 533
Large-scale testing (Phase 3)Study completedNCT00509418
What this trial is testing

Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis

Who this might be right for
Nonalcoholic Steatohepatitis
Catalysis SL 60
Not applicableUnknownNCT05220956
What this trial is testing

Impact of Time-restricted Feeding in NAFLD

Who this might be right for
Fatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic
Johannes Gutenberg University Mainz 100
Not applicableUnknownNCT03725631
What this trial is testing

Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD

Who this might be right for
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
Korea University Guro Hospital 150
Not applicableNot Yet RecruitingNCT06601361
What this trial is testing

Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital

Who this might be right for
NAFLD - Nonalcoholic Fatty Liver Disease
Assiut University 112
Not applicableStudy completedNCT02983669
What this trial is testing

The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver Disease

Who this might be right for
Fatty LiverFatty Liver, Nonalcoholic
Shiraz University of Medical Sciences 86
Large-scale testing (Phase 3)Study completedNCT00650546
What this trial is testing

Role of Exenatide in NASH-a Pilot Study

Who this might be right for
Nonalcoholic Fatty Liver Disease
Indiana University 8
Not applicableUnknownNCT02992470
What this trial is testing

Crassostrea Gigas for Liver Health

Who this might be right for
Nonalcoholic Fatty Liver
Korean Medicine Hospital of Pusan National University 96
Not applicableStudy completedNCT00274183
What this trial is testing

Nonalcoholic Fatty Liver Disease in Taiwanese Children

Who this might be right for
Fatty Liver
Far Eastern Memorial Hospital 614
Post-approval studies (Phase 4)Study completedNCT01208649
What this trial is testing

Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Nonalcoholic Fatty Liver Disease
Ruhr University of Bochum 13
Testing effectiveness (Phase 2)Study completedNCT05039450
What this trial is testing

Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc 213
Early research (Phase 1)Study completedNCT04463017
What this trial is testing

Ascending Dose Study of HU6 in Healthy Volunteers

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Rivus Pharmaceuticals, Inc. 64
Not applicableStudy completedNCT04774302
What this trial is testing

Correlation Between Hepatic Fibrosis and Cardiovascular Risk Evaluated by Non-invasive Tests in Patients With NAFLD

Who this might be right for
NAFLD
Clinique Pasteur 292
Next Page